Fortress Biotech, Inc. — SEC Form 4 filings
SEC reporting owner CIK 1429260. 13 Form 4 filings on record with FilingPulse; latest filed 2026-01-06.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-22 to 2026-01-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 100,000 shares, $129,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 100,000 shares @ $1.29 ($129,000) in Checkpoint Therapeutics, Inc., filed 2025-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Checkpoint Therapeutics, Inc. (CKPT) | 10% owner | 5 | — | 1 leg · 100,000 sh · $129,000 | 7 |
| Journey Medical Corp (DERM) | 10% owner | 1 | — | — | 5 |
| MUSTANG BIO, INC. (MBIO) | 10% owner | 4 | — | — | 4 |
| AVENUE THERAPEUTICS, INC. (ATXI) | 10% owner | 3 | — | — | 3 |
Form 4 filings — Fortress Biotech, Inc.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-06 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 111,209 @ $0 | EDGAR |
| 2026-01-05 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 278,385 @ $0 | EDGAR |
| 2025-10-01 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 59,334 @ $0 | EDGAR |
| 2025-06-03 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Sale (S): 100,000 @ $1.29 · Disposition to issuer (D): 6,122,249 @ $4.10 · Disposition to issuer (D): 700,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 67,806 @ $0 | EDGAR |
| 2025-04-02 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 33,724 @ $0 | EDGAR |
| 2025-02-27 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 18,500 @ $0 | EDGAR |
| 2025-01-03 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 81,407 @ $0 · Grant/award (A): 2,386,808 @ $0 | EDGAR |
| 2024-10-01 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 146,341 @ $0 | EDGAR |
| 2024-06-28 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 575,191 @ $0 | EDGAR |
| 2024-05-31 | 4 | Journey Medical Corp (DERM) | Other (J): 50,000 @ $0 · Other (J): 50,000 @ $0 · Other (J): 50,000 @ $0 · Other (J): 50,000 @ $0 · Other (J): 50,000 @ $0 | EDGAR |
| 2024-04-17 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 413,507 @ $0 | EDGAR |
| 2024-03-22 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 193,905 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1429260 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →